Top Story

Publication Exclusive: Noninvasive OCT angiography allows for detailed visualization of retinal vasculature

Publication Exclusive: Noninvasive OCT angiography allows for detailed visualization of retinal vasculature
December 1, 2015

September’s announcement by Carl Zeiss Meditec that its AngioPlex OCT angiography technology had received 510(k) clearance from the FDA set the stage for other systems to likely also soon become commercialized in the U.S. The technology allows extreme close-up imaging of the retinal vasculature for assessing retinal vascular diseases and holds potential for guiding treatment decisions and monitoring patient responses to therapy.

“Over the past 20 years, OCT has developed rapidly as a ‘noninvasive’ method of imaging for medical diagnosis and defining activity criteria, such as intra/subretinal fluid, hyper-reflective dots and dense intraretinal areas,” Gabriel J. Coscas, MD, emeritus professor of ophthalmology at the University of Paris XII in Créteil, France, said. But over the past 2 years, it was found that additional information useful for treatment decisions can now be gained with OCT angiography (OCTA).

Meeting News CoverageVideo

VIDEO: Surgeon reviews new iridectomy technique

December 1, 2015
LAS VEGAS — At the American Academy of Ophthalmology annual meeting, Priya Narang, MS, explains a new technique for performing peripheral iridectomy for eyes undergoing…

ANSI updates recommendations for ophthalmic lenses

November 30, 2015
The Vision Council announced that the American National Standards Institute has published the 2015 revision of Standard Z80.1, Prescription of Ophthalmic Lenses –…
In the JournalsPerspective

Study finds 5% incidence of IOL opacification after DSEK

November 30, 2015
IOL opacification was identified in 5% of eyes that underwent Descemet’s stripping endothelial keratoplasty, according to one study.Investigators retrospectively…
Business News

Phase 3 clinical trial enrollment begins for ocular allergy drug

November 30, 2015
Enrollment is underway for a second phase 3 clinical trial of Dextenza sustained release dexamethasone for treatment of allergic conjunctivitis, according to a press…
More News Headlines »
Meeting News Coverage

Improvements in visual acuity with corneal inlay remain stable long-term

November 16, 2015
NEW ORLEANS – A study involving 253 subjects who received the Kamra corneal inlay in their nondominant eye showed…
More »

Arizona allows sale of adjustable focus eye wear without prescription

October 29, 2015
Arizona now permits the sale of adjustable eye wear without a prescription, based on a ruling by the assistant attorney…
More »

Allergan seeks approval for preservative-free Restasis

November 13, 2015
Allergan announced it has submitted a Prior Approval Supplement for Restasis 0.05% to obtain marketing clearance for a…
More »
Current Issues
View the Current Issue
Primary Care Optometry News